3
Recognized as IHT by Developed & Manufactured by 300,000+ Women Screened 200+ Installations Worldwide 10+ Regulatory Approvals 10+ International Patents 15+ Grants & Awards Early detection. For women everywhere. Identify breast lumps at an early stage, quickly & easily, without pain or radiation ISO 13485 WHO-GMP Market cleared by

Early detection. For women everywhere

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Recognized as IHT by Developed & Manufactured by

300,000+Women Screened

200+Installations Worldwide

10+Regulatory Approvals

10+International Patents

15+Grants & Awards

Early detection. For women everywhere.Identify breast lumps at an early stage, quickly & easily, without pain or radiation

ISO 13485 WHO-GMP

Market cleared by

Right Breast No findings Left Breast No findings

A-102, Universal ParadiseNanda Patkar Rd

Vile Parle (E), Mumbai 400057

Phone: 022 2610 [email protected]

[ ] Symptoms

[ ] Family History

[ ] SurvioriBreastExam indicates No findings in

Left Breast, and No findings in Right Breast.

Jane Doe

Exam Date: 09 May, 2018

Age: 37 Yrs

Finding:

Breast cancer is the most common

cancer in women globally

With limited access to early

detection, most cases present

late, with poor prognosis

Early Detection Challenges

High CostFew Doctors

Pain & Radiation

Sta

ge

of

de

tec

tio

n

ComplexEasy

User Prociency Level

S = Screening Tool

D = Diagnostic Tool

Not adoptable for Screening

in Developing Countries

DigitalMammography

DS

Breast MRI

3D Mammo

D

DS

SClinical Breast

ExamBreast Ultrasound

D

FilmMammography

DS

Total Cost of Ownership (Equipment, Maintenance, Manpower)

S

LED Torch S

Self Breast Exam

S

Operable & Scalable in Limited Resource Settings

Ultra Portable. Wireless. Battery Powered. Cloud Connected.

Minimal Training. Instant Results. Point-of-Care. Low Cost.

iBreastExam

enables earlier

stage detection

at low-cost and

minimal training,

compared to

other options

Mammography

Breast Ultrasound

Clinical Breast Exam

“Gold Standard”Modalities

✔ ✔

Accessible& Affordable

Easy to Use& Train

Scalable &Connected

Standardized & Objective

Clinical Study Title, & Year Sensitivity Specicity NPV PPV Benchmarked By

84% 94% 98% 60% Mammogram, USG & CBE

86% 89% 96% 70% Mammogram & USG

87% 88% 75% 61% Mammogram

A cost-effective handheld breast scanner for use in low-resource environments: a validation study. Published in WJSO, October 2016

Noninvasive and Low-Cost Technique for Early Detection of Clinically Relevant Breast Lesions. Published in IJGO, June 2016

Breast Tumor Detection using Capacitive Sensor: First Clinical Report. Published in JACS, June 2013

+1.631.980.8340 (US Ofce) | +91.22.26102610 (India Ofce) | +60.3.62064996 (Malaysia Ofce)

[email protected] facebook.com/ibreastexamiBreastExam.com

R

Asia

nearly 1 Million scans

sold in 12 countries

Awards & Recognition

Lyfebulb-Helsinn Oncology Innovation

Award 2019

Bayer FoundationGrants 4 Impact

Award 2018

Best Pitch Innov8Talks Arab Health

Award 2019